Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
|
CN |
|
S
|
Shanxi Huaxiang Group Co Ltd
SSE:603112
|
CN |
|
Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460
|
CN |
|
Shake Shack Inc
NYSE:SHAK
|
US |
|
D
|
Daishinku Corp
TSE:6962
|
JP |
|
Tyson Foods Inc
NYSE:TSN
|
US |
|
K
|
Kilitch Drugs (India) Ltd
NSE:KILITCH
|
IN |
|
X
|
Xerox Holdings Corp
XETRA:XER2
|
US |
|
A
|
AECC Aero Science and Technology Co Ltd
SSE:600391
|
CN |
|
D
|
Delta Technologies Nyrt
BET:DELTA
|
HU |
|
Deutsche Wohnen SE
OTC:DTCWY
|
DE |
|
S
|
Sical Logistics Ltd
NSE:SICALLOG
|
IN |
|
Pacific Textiles Holdings Ltd
HKEX:1382
|
HK |
|
C
|
Credit Bureau Asia Ltd
SGX:TCU
|
SG |
|
W
|
Wooshin Systems Co Ltd
KRX:017370
|
KR |
Beijing Kawin Technology Share-holding Co Ltd
Beijing Kawin Technology Share-Holding Co., Ltd. provides biotechnology treatment solutions and medicines. The company is headquartered in Beijing, Beijing and currently employs 647 full-time employees. The company went IPO on 2021-02-08. The firm's recombinant human interferon α2b and compound glycyrrhizin drugs are applied to treat viral diseases. The firm mainly distributes its products within domestic market.
Beijing Kawin Technology Share-Holding Co., Ltd. provides biotechnology treatment solutions and medicines. The company is headquartered in Beijing, Beijing and currently employs 647 full-time employees. The company went IPO on 2021-02-08. The firm's recombinant human interferon α2b and compound glycyrrhizin drugs are applied to treat viral diseases. The firm mainly distributes its products within domestic market.
